Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CRTD Volume +5M
Float 11.77M
Third quarter net revenues increased 178% YoY and 22% QoQ
Revenue guidance for FY 2022 $10 - $15 million, a 100+% increase over expected FY 2021 revenues.
$CRTD Volume +5M
Float 11.77M
Third quarter net revenues increased 178% YoY and 22% QoQ
Revenue guidance for FY 2022 $10 - $15 million, a 100+% increase over expected FY 2021 revenues.
REDU??
$SNDL Upgrades coming soon. IMO
$SNDL Upgrades coming soon. IMO
$SNDL Share Repurchase C $100M
Asset value per share at September 30, 2021, (US$1.1 billion or US$0.55 per share)
https://finance.yahoo.com/news/sundial-reports-third-quarter-2021-234700996.html
Shares on Loan 409.93M (Source: ORTEX)
Utilization 98.34%
Strong candidate for a short squeeze
$SNDL Share Repurchase C $100M
Asset value per share at September 30, 2021, (US$1.1 billion or US$0.55 per share)
https://finance.yahoo.com/news/sundial-reports-third-quarter-2021-234700996.html
Shares on Loan 409.93M (Source: ORTEX)
Utilization 98.34%
Strong candidate for a short squeeze
$OTRK 52 Week high $99
Current Price $9
Drop $90
Float 10M
% Held by Insiders 53.23%
% Held by Institutions 30.69%
Short Interest 28.93%
News about new contract will send it much higher
"- Company in Advanced Discussions with 4 Employer Organizations and Several Providers"
$OTRK 52 Week high $99
Current Price $9
Drop $90
Float 10M
% Held by Insiders 53.23%
% Held by Institutions 30.69%
Short Interest 28.93%
News about new contract will send it much higher
"- Company in Advanced Discussions with 4 Employer Organizations and Several Providers"
$MRNA One of the top mRNA technology
52 Week high $497
Current price $230
Drop $267
Price Target announce on Friday 11/5/2021
Morgan Stanley $313
Jefferies $325
Goldman Sachs $395
Barclays $404
$MRNA 30 drugs in the pipeline, not only COVID-19 Vaccine
3 Gaps to fill on the Daily Chart, and oversold RSI (14) at 25
50 SMA support at $230 on the Weekly Chart
Moderna Is Melting - Why I Am Buying This Dip
https://seekingalpha.com/article/4466169-moderna-is-melting-why-i-am-buying-this-dip?mail_subject=mrna-moderna-is-melting-why-i-am-buying-this-dip&utm_campaign=rta-stock-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha
Moderna Stock Just Became A Strong Buy
https://seekingalpha.com/article/4466561-moderna-mrna-stock-strong-buy?mail_subject=mrna-moderna-stock-just-became-a-strong-buy&utm_campaign=rta-stock-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha
$MRNA One of the top mRNA technology
52 Week high $497
Current price $230
Drop $267
Price Target announce on Friday 11/5/2021
Morgan Stanley $313
Jefferies $325
Goldman Sachs $395
Barclays $404
$MRNA 30 drugs in the pipeline, not only COVID-19 Vaccine
3 Gaps to fill on the Daily Chart, and oversold RSI (14) at 25
50 SMA support at $230 on the Weekly Chart
Moderna Is Melting - Why I Am Buying This Dip
https://seekingalpha.com/article/4466169-moderna-is-melting-why-i-am-buying-this-dip?mail_subject=mrna-moderna-is-melting-why-i-am-buying-this-dip&utm_campaign=rta-stock-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha
Moderna Stock Just Became A Strong Buy
https://seekingalpha.com/article/4466561-moderna-mrna-stock-strong-buy?mail_subject=mrna-moderna-stock-just-became-a-strong-buy&utm_campaign=rta-stock-article&utm_content=link-0&utm_medium=email&utm_source=seeking_alpha
$MRNA $222 down $124 in 2 days
Today Price Target 395 Goldman Sachs
$MRNA $222 down $124 in 2 days
Today Price Target 313, 325, 404 Morgan Stanely, Jefferies and Barclays
$OTRK Volume +22M at all time high!
Float 9.75M
Short Interest 28.93% ~ 33.16%
$OTRK Volume +22M at all time high!
Float 9.75M
Short Interest 28.93% ~ 33.16%
$OTRK Volume +13M at all time high!
$OTRK Volume +13M at all time high!
$OTRK Waiting for upgrades!
$OTRK EPS beats by $0.27, beats on revenue; raises full-year revenue guidance
https://seekingalpha.com/news/3765512-ontrak-eps-beats-by-027-beats-on-revenue-raises-full-year-revenue-guidance
$OTRK Waiting for upgrades!
$OTRK EPS beats by $0.27, beats on revenue; raises full-year revenue guidance
https://seekingalpha.com/news/3765512-ontrak-eps-beats-by-027-beats-on-revenue-raises-full-year-revenue-guidance
$OTRK
- Sales Pipeline Accelerating and Advancing with 3 of Nation’s Larger Health Plans
- Company in Advanced Discussions with 4 Employer Organizations and Several Providers
- Current National Plan Customer Signs Contract to Expand Ontrak Program to Include Mobile Care Solution
$OTRK
- Sales Pipeline Accelerating and Advancing with 3 of Nation’s Larger Health Plans
- Company in Advanced Discussions with 4 Employer Organizations and Several Providers
- Current National Plan Customer Signs Contract to Expand Ontrak Program to Include Mobile Care Solution
$OTRK EPS beats by $0.27, beats on revenue; raises full-year revenue guidance
https://seekingalpha.com/news/3765512-ontrak-eps-beats-by-027-beats-on-revenue-raises-full-year-revenue-guidance
$OTRK EPS beats by $0.27, beats on revenue; raises full-year revenue guidance
https://seekingalpha.com/news/3765512-ontrak-eps-beats-by-027-beats-on-revenue-raises-full-year-revenue-guidance
$FCEL! I am in
$OTRK $10.39 above 50 SMA
Earnings today
$OTRK today Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock
https://finance.yahoo.com/news/ontrak-declares-quarterly-dividend-9-200500606.html
$OTRK $10.39 above 50 SMA
Earnings today
$OTRK today Declares Quarterly Dividend on 9.50% Non-Convertible Series A Preferred Stock
https://finance.yahoo.com/news/ontrak-declares-quarterly-dividend-9-200500606.html
$OTRK ANALYST PRICE TARGET CONSENSUS $22
Shares Outstanding 19.15M
Float 8.3M
Short Interest 27.58% ~ 33.16%
% Insiders own 55.72%
% Institutions own 30.80%
52 Week Range $8.46 - $99.89
Will run hard with volume. Earnings Tomorrow.
Ontrak: Why You Should Buy The Dip
https://seekingalpha.com/article/4461144-ontrak-why-you-should-buy-the-dip
$OTRK marching to 50 SMA $10.13
$OTRK ANALYST PRICE TARGET CONSENSUS $22
Shares Outstanding 19.15M
Float 8.3M
Short Interest 27.58% ~ 33.16%
% Insiders own 55.72%
% Institutions own 30.80%
52 Week Range $8.46 - $99.89
Will run hard with volume. Earnings Tomorrow.
Ontrak: Why You Should Buy The Dip
https://seekingalpha.com/article/4461144-ontrak-why-you-should-buy-the-dip
$OTRK marching to 50 SMA $10.13
$OTRK ANALYST PRICE TARGET CONSENSUS $22
Shares Outstanding 19.15M
Float 8.3M
Short Interest 29.71% ~ 33.16%
% Insiders own 55.72%
% Institutions own 30.80%
52 Week Range $8.46 - $99.89
Ontrak: Why You Should Buy The Dip
https://seekingalpha.com/article/4461144-ontrak-why-you-should-buy-the-dip
$OTRK ANALYST PRICE TARGET CONSENSUS $22
Shares Outstanding 19.15M
Float 8.3M
Short Interest 29.71% ~ 33.16%
% Insiders own 55.72%
% Institutions own 30.80%
52 Week Range $8.46 - $99.89
Ontrak: Why You Should Buy The Dip
https://seekingalpha.com/article/4461144-ontrak-why-you-should-buy-the-dip